FSMEX Holdings — Select Medical Technology and Devices Portfolio

All 55 reported holdings of Select Medical Technology and Devices Portfolio (FSMEX) by percentage of net assets, from the fund's latest SEC N-PORT filing.

Holding% of net assetsValue (USD)
Danaher Corp.15.09%$449.37M
Thermo Fisher Scientific, Inc.14.06%$418.63M
Intuitive Surgical, Inc.7.45%$221.87M
Boston Scientific Corp.5.11%$152.18M
Edwards Lifesciences Corp.4.21%$125.38M
Stryker Corp.4.18%$124.48M
Abbott Laboratories3.85%$114.70M
Waters Corp.3.27%$97.43M
Agilent Technologies, Inc.3.21%$95.70M
West Pharmaceutical Svcs, Inc.3.09%$92.00M
Fidelity Revere Street Trust2.89%$86.14M
Bio Techne Corp.2.85%$84.76M
Repligen Corp.2.17%$64.45M
10x Genomics, Inc.1.96%$58.46M
Guardant Health, Inc.1.86%$55.51M
Irhythm Technologies, Inc.1.72%$51.26M
Sartorius Stedim Biotech1.71%$50.90M
Caris Life Sciences, Inc.1.68%$50.16M
Natera, Inc.1.56%$46.46M
Veracyte, Inc.1.56%$46.34M
Medline, Inc.1.54%$45.70M
Illumina, Inc.1.53%$45.63M
Bruker Corp.1.50%$44.76M
Align Technology, Inc.1.09%$32.37M
Waystar Holding Corp.1.07%$31.86M
Iqvia Holdings, Inc.1.06%$31.70M
Kardium Inc/us1.04%$31.11M
Lifestance Health Group, Inc.1.03%$30.71M
Insulet Corp.1.01%$30.15M
Heartflow, Inc.0.99%$29.43M
Lantheus Holdings, Inc.0.93%$27.80M
Kestra Medical Technologies, Inc.0.68%$20.20M
Element Biosciences, Inc.0.56%$16.77M
Twist Bioscience Corp.0.56%$16.72M
Minimed Group, Inc.0.52%$15.41M
Veeva Sys, Inc.0.50%$14.82M
Fidelity Revere Street Trust0.48%$14.27M
Shoulder Innovations, Inc.0.47%$13.93M
10x Genomics, Inc.0.37%$11.12M
Freenome, Inc.0.36%$10.64M
Revvity, Inc.0.28%$8.36M
Ceribell, Inc.0.26%$7.68M
Aledade, Inc.0.25%$7.50M
Galvanize Therapeutics0.22%$6.63M
BECTON DICKINSON and CO0.20%$5.88M
Almar Biosciences, Inc.0.19%$5.72M
Manus Bio, Inc.0.19%$5.71M
Icu Medical, Inc.0.18%$5.42M
Dna Script Sas0.15%$4.41M
Asimov, Inc.0.08%$2.43M
Dmed Biopharmaceutical Co. Ltd.0.06%$1.86M
Saluda Medical, Inc.0.03%$758.34K
Elevatebio, LLC0.01%$395.05K
Conformal Medical, Inc.0.00%$106.17K
Prognomiq, Inc.0.00%$75.70K

FSMEX overview: performance, fees, allocation and SEC filings